Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has shared an update.
ASKA Pharmaceutical Holdings Co., Ltd. announced organizational and personnel changes effective April 1, 2025, for its subsidiary ASKA Pharmaceutical Co., Ltd. The Production Control Department will be renamed as the Supply Chain Management Department, reflecting a strategic shift in focus. Several key personnel changes were also made to streamline operations, indicating an emphasis on enhancing administrative and production capabilities within the company.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the production and supply of pharmaceutical products. The company’s primary services include drug manufacturing and distribution with an emphasis on quality and safety assurance.
YTD Price Performance: -6.48%
Average Trading Volume: 52,966
Technical Sentiment Consensus Rating: Hold
Current Market Cap: Yen55.4B
See more insights into 4886 stock on TipRanks’ Stock Analysis page.